# Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

> **NCT07553754** · — · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Prostate Cancer (Diagnosis)
- Bone Metastasis
- PSMA PET
- Liquid Biopsy
- Exosomal RNA
- Biomarker Discovery and Validation
- Treament-naive

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07553754
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-12
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553754, "Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07553754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*